MSB 2.17% $1.13 mesoblast limited

Ann: Key Day 100 Survival Results In P3 GvHD Trial, page-27

  1. 2,024 Posts.
    lightbulb Created with Sketch. 315
    Honestly who would sell on this news, defies logic really, there is a huge potential here for the next level approvals, ASX just a sad case of ho-hum +5c really?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.